Scheiber-Mojdehkar B - Search Results

1

Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial.

Nachbauer W, Hering S, Seifert M, Steinkellner H, Sturm B, Scheiber-Mojdehkar B, Reindl M, Strasak A, Poewe W, Weiss G, Boesch S. Nachbauer W, et al. Cerebellum. 2011 Dec;10(4):763-9. doi: 10.1007/s12311-011-0287-9. Cerebellum. 2011. PMID: 21597884 Clinical Trial.

2

Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin.

Boesch S, Sturm B, Hering S, Goldenberg H, Poewe W, Scheiber-Mojdehkar B. Boesch S, et al. Ann Neurol. 2007 Nov;62(5):521-4. doi: 10.1002/ana.21177. Ann Neurol. 2007. PMID: 17702040 Clinical Trial.

3

Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial.

Boesch S, Sturm B, Hering S, Scheiber-Mojdehkar B, Steinkellner H, Goldenberg H, Poewe W. Boesch S, et al. Mov Disord. 2008 Oct 15;23(13):1940-4. doi: 10.1002/mds.22294. Mov Disord. 2008. PMID: 18759345 Clinical Trial.

4

Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor.

Sturm B, Helminger M, Steinkellner H, Heidari MM, Goldenberg H, Scheiber-Mojdehkar B. Sturm B, et al. Eur J Clin Invest. 2010 Jun;40(6):561-5. doi: 10.1111/j.1365-2362.2010.02292.x. Epub 2010 Apr 28. Eur J Clin Invest. 2010. PMID: 20456483

5

Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia.

Nachbauer W, Wanschitz J, Steinkellner H, Eigentler A, Sturm B, Hufler K, Scheiber-Mojdehkar B, Poewe W, Reindl M, Boesch S. Nachbauer W, et al. Mov Disord. 2011 Aug 15;26(10):1935-8. doi: 10.1002/mds.23789. Epub 2011 Jun 20. Mov Disord. 2011. PMID: 21692115 Clinical Trial.

6

Recombinant human erythropoietin: effects on frataxin expression in vitro.

Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J, Goldenberg H, Scheiber-Mojdehkar B. Sturm B, et al. Eur J Clin Invest. 2005 Nov;35(11):711-7. doi: 10.1111/j.1365-2362.2005.01568.x. Eur J Clin Invest. 2005. PMID: 16269021

7

Intravenous iron preparations and ascorbic acid: effects on chelatable and bioavailable iron.

Sturm B, Laggner H, Ternes N, Goldenberg H, Scheiber-Mojdehkar B. Sturm B, et al. Kidney Int. 2005 Mar;67(3):1161-70. doi: 10.1111/j.1523-1755.2005.00183.x. Kidney Int. 2005. PMID: 15698458 Free article.

8

A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels.

Steinkellner H, Scheiber-Mojdehkar B, Goldenberg H, Sturm B. Steinkellner H, et al. Anal Chim Acta. 2010 Feb 5;659(1-2):129-32. doi: 10.1016/j.aca.2009.11.036. Epub 2009 Nov 27. Anal Chim Acta. 2010. PMID: 20103114

9

White matter changes in patients with friedreich ataxia after treatment with erythropoietin.

Egger K, Clemm von Hohenberg C, Schocke MF, Guttmann CR, Wassermann D, Wigand MC, Nachbauer W, Kremser C, Sturm B, Scheiber-Mojdehkar B, Kubicki M, Shenton ME, Boesch S. Egger K, et al. J Neuroimaging. 2014 Sep-Oct;24(5):504-8. doi: 10.1111/jon.12050. Epub 2013 Sep 9. J Neuroimaging. 2014. PMID: 24015771 Free PMC article. Clinical Trial.

10

No changes in heme synthesis in human Friedreich´s ataxia erythroid progenitor cells.

Steinkellner H, Singh HN, Muckenthaler MU, Goldenberg H, Moganty RR, Scheiber-Mojdehkar B, Sturm B. Steinkellner H, et al. Among authors: scheiber mojdehkar b. Gene. 2017 Jul 20;621:5-11. doi: 10.1016/j.gene.2017.04.014. Epub 2017 Apr 12. Gene. 2017. PMID: 28412459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters